LabAutomation 2006 - SLAS

Where Laboratory Technologies Emerge and Merge
3:00 pm Page 56 Applying Biomarkers to Early Drug Development; Scott Patterson, Amgen, Inc.
3:30 pm Page 57
4:00 pm Page 57
4:30 pm Page 58
3:00 – 5:00 pm
Pasadena,
Wyndham
Hotel
3:00 pm Page 66
3:30 pm Page 67
4:00 pm Page 67
4:30 pm Page 68
3:00 – 5:00 pm
Learning
Center,
Wyndham
Hotel
3:00 pm Page 76
3:30 pm Page 77
4:00 pm Page 77
4:30 pm Page 78
3:00 – 5:00 pm
Madera,
Wyndham
Hotel
3:00 pm Page 86
3:30 pm Page 87
4:00 pm Page 87
Toward Lymphoma Biomarkers: Deep Look Mass Spectrometry Based Expression
Profiling, Identification and Validation of Cerebrospinal Fluid
James Rubenstein, University of California, San Francisco
A Small Number of Genes are Sufficient to Classify a Large Number of Unique
Toxicological and Pharmacological End-Points Using Gene Expression
Kurt Jarnagin, Iconix Pharmaceuticals, Inc.
Metabolomics: A Non-Linear Approach to Metabolite Profiling;
Elizabeth Want, The Scripps Research Institute
Micro and Nanoscale Separations Micro- and Nanotechnologies – Track 2
Chair: Dana Spence, Wayne State University
Coupling Valving and Microchip-Based Separations for Analyzing
Neurotransmitters Released From Cells; R. Scott Martin, Saint Louis University
Nanofluidics and Mass-Limited Chemical Analysis: Nanocapillary Array
Membranes as Switchable Fluidic Elements for Multidimensional Analyses
Paul Bohn, University of Illinois
Multidimensional Separations of Peptides on Microfluidic Devices
Stephen C. Jacobson, Indiana University
Microdevices With Integrated Sample Preparation for Ultrafast Sample-In/
Answer-Out Genetic Analysis; James Landers, University of Virginia
High-Throughput Value in Proteomic High-Throughput Technologies – Track 3
and Genomic Technology
Chair: Jay Strum, GlaxoSmithKline
Automation and Miniaturization of TaqMan Assays to Support Drug Discovery
Jay Strum, GlaxoSmithKline
Quantitative Multiplexed Gene Expression Profiling
Joe Monforte, Althea Technologies, Inc.
High Throughput, High Content Gene Expression-Based Target Validation Using
Cells, Fixed or Frozen Tissue, and Whole Organisms to Define the Systems
Biology and Characterize Compound and Stimulus Activity Based on Dose
Response EC50 Studies; Bruce Seligmann, HTG
Automated Profiling and Identification of Endogenous Peptidomic Markers
in Human Plasma; Maija Partanen
Integrated Informatics in the Automation Laboratory Informatics – Track 4
Chair: Chris McKenna, Symyx, Inc.
Interchanging Analytical Data and Metadata Using the Analytical Information
Markup Language (ANIML); Gary Kramer, National Institute of Standards and Technology
The Impact of Software and Hardware Interoperability on Efficiency in an
Automated Solubility Determination Workflow; Erik Rubin, Bristol-Myers Squibb Co.
Pathways for Biological Reagent Quality and Workflow Tracking (CIMS)
Julian Willmott, White Carbon
4:30 pm Page 88 An Enterprise Platform for Data and Application Integration; Ton van Daelen, SciTegic
3:00 – 5:00 pm
Sierra/
Ventura,
Wyndham
Hotel
3:00 pm Page 96
3:00 pm Page 97
4:00 pm Page 97
Multipurpose Emerging Technologies Frontiers Beyond BioPharma – Track 5
and Management Trends
Chair: William Sonnefeld, Sonnefeld Associates Inc.
Petroleomics: Mass Spectrometry Returns to Its Roots
Ryan P. Rodgers, National High Magnetic Field Lab
Rapid, High-Throughput Bacterial Genotyping to Reduce Healthcare-Associated
Infections; David Ecker, Isis Pharmaceuticals Inc.
All-Optical-Logic Microfluidic Circuit for Biochemical and Cellular Analysis
Powered by Photoactive Nanoparticles; Gang L. Liu, University of California, Berkeley
29